Litcius/Paper detail

Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor

Matteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, Raluca Marian, Francesco Cantiello, Gennaro Musi, Savino M. Di Stasi, Rodolfo Hurle, Giorgio Guazzoni, Gian Maria Busetto, Francesco Del Giudice, Sisto Perdonà, Paola Del Prete, Vincenzo Mirone, Marco Borghesi, Angelo Porreca, Walter Artibani, Pierluigi Bove, Estêvão Lima, Riccardo Autorino, Nicolae Crişan, Abdal Rahman Abu Farhan, Michele Battaglia, Pasquale Ditonno, Vincenzo Serretta, Giorgio Ivan Russo, Daniela Terracciano, Giuseppe Di Lorenzo, Rocco Damiano, Guru Sonpavde, Mihai Dorin Vartolomei, Ottavio De Cobelli, Giuseppe Lucarelli

2020Urologic Oncology Seminars and Original Investigations48 citationsDOI

Topics & Concepts

MedicineHazard ratioBladder cancerInternal medicineConfidence intervalUrologyClinical endpointProportional hazards modelLymphovascular invasionCohortType 2 Diabetes MellitusOncologyCancerDiabetes mellitusMetastasisRandomized controlled trialEndocrinologyBladder and Urothelial Cancer TreatmentsInflammatory Biomarkers in Disease PrognosisFerroptosis and cancer prognosis
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor | Litcius